A citation-based method for searching scientific literature

Mei Qin, Julia Kang, Thomas V Burlin, Chunhui Jiang, Carolyn Beebe Smith. J Neurosci 2005
Times Cited: 169







List of co-cited articles
1370 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
Jennifer C Darnell, Sarah J Van Driesche, Chaolin Zhang, Ka Ying Sharon Hung, Aldo Mele, Claire E Fraser, Elizabeth F Stone, Cynthia Chen, John J Fak, Sung Wook Chi,[...]. Cell 2011
59

Correction of fragile X syndrome in mice.
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
689
57


Dysregulation of mTOR signaling in fragile X syndrome.
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
397
42

The mGluR theory of fragile X mental retardation.
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
40

Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
963
39

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
Aubin Michalon, Michael Sidorov, Theresa M Ballard, Laurence Ozmen, Will Spooren, Joseph G Wettstein, Georg Jaeschke, Mark F Bear, Lothar Lindemann. Neuron 2012
348
34

Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome.
Emily K Osterweil, Shih-Chieh Chuang, Alexander A Chubykin, Michael Sidorov, Riccardo Bianchi, Robert K S Wong, Mark F Bear. Neuron 2013
155
30

The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.
Ilaria Napoli, Valentina Mercaldo, Pietro Pilo Boyl, Boris Eleuteri, Francesca Zalfa, Silvia De Rubeis, Daniele Di Marino, Evita Mohr, Marzia Massimi, Mattia Falconi,[...]. Cell 2008
401
29

Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Aditi Bhattacharya, Hanoch Kaphzan, Amanda C Alvarez-Dieppa, Jaclyn P Murphy, Philippe Pierre, Eric Klann. Neuron 2012
209
29

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
A J Verkerk, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang. Cell 1991
26

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.
V Brown, P Jin, S Ceman, J C Darnell, W T O'Donnell, S A Tenenbaum, X Jin, Y Feng, K D Wilkinson, J D Keene,[...]. Cell 2001
850
26

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Christina Gross, Mika Nakamoto, Xiaodi Yao, Chi-Bun Chan, So Y Yim, Keqiang Ye, Stephen T Warren, Gary J Bassell. J Neurosci 2010
185
26

Evidence that fragile X mental retardation protein is a negative regulator of translation.
B Laggerbauer, D Ostareck, E M Keidel, A Ostareck-Lederer, U Fischer. Hum Mol Genet 2001
439
26


The fragile X mental retardation protein inhibits translation via interacting with mRNA.
Z Li, Y Zhang, L Ku, K D Wilkinson, S T Warren, Y Feng. Nucleic Acids Res 2001
351
24



Mutations causing syndromic autism define an axis of synaptic pathophysiology.
Benjamin D Auerbach, Emily K Osterweil, Mark F Bear. Nature 2011
419
22

Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.
Lingfei Hou, Marcia D Antion, Daoying Hu, Corinne M Spencer, Richard Paylor, Eric Klann. Neuron 2006
348
21

Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.
T A Comery, J B Harris, P J Willems, B A Oostra, S A Irwin, I J Weiler, W T Greenough. Proc Natl Acad Sci U S A 1997
769
21

The autistic neuron: troubled translation?
Raymond J Kelleher, Mark F Bear. Cell 2008
411
20

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
Michael R Santoro, Steven M Bray, Stephen T Warren. Annu Rev Pathol 2012
352
19

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Christina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, Matthew Shumway, Rebecca S Hammond, Friso R Postma, Christopher Brynczka, Roger Rush, Alexia Thomas, Richard Paylor,[...]. Sci Transl Med 2012
175
19

Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling.
Ravi S Muddashetty, Vijayalaxmi C Nalavadi, Christina Gross, Xiaodi Yao, Lei Xing, Oskar Laur, Stephen T Warren, Gary J Bassell. Mol Cell 2011
268
17

Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
T V Bilousova, L Dansie, M Ngo, J Aye, J R Charles, D W Ethell, I M Ethell. J Med Genet 2009
317
17

The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses.
Francesca Zalfa, Marcello Giorgi, Beatrice Primerano, Annamaria Moro, Alessandra Di Penta, Surya Reis, Ben Oostra, Claudia Bagni. Cell 2003
517
17

Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory.
François V Bolduc, Kimberly Bell, Hilary Cox, Kendal S Broadie, Tim Tully. Nat Neurosci 2008
158
17

FMR1 protein: conserved RNP family domains and selective RNA binding.
C T Ashley, K D Wilkinson, D Reines, S T Warren. Science 1993
582
17


Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function.
J C Darnell, K B Jensen, P Jin, V Brown, S T Warren, R B Darnell. Cell 2001
728
16

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Sébastien Jacquemont, Aurore Curie, Vincent des Portes, Maria Giulia Torrioli, Elizabeth Berry-Kravis, Randi J Hagerman, Feliciano J Ramos, Kim Cornish, Yunsheng He, Charles Paulding,[...]. Sci Transl Med 2011
256
16

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
C A Hoeffer, E Sanchez, R J Hagerman, Y Mu, D V Nguyen, H Wong, A M Whelan, R S Zukin, E Klann, F Tassone. Genes Brain Behav 2012
128
16

Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice.
Mei Qin, Kathleen C Schmidt, Alan J Zametkin, Shrinivas Bishu, Lisa M Horowitz, Thomas V Burlin, Zengyan Xia, Tianjiang Huang, Zenaide M Quezado, Carolyn Beebe Smith. J Cereb Blood Flow Metab 2013
34
47

Dysregulation and restoration of translational homeostasis in fragile X syndrome.
Joel D Richter, Gary J Bassell, Eric Klann. Nat Rev Neurosci 2015
157
16



Dendritic spine structural anomalies in fragile-X mental retardation syndrome.
S A Irwin, R Galvez, W T Greenough. Cereb Cortex 2000
451
15


FMRP targets distinct mRNA sequence elements to regulate protein expression.
Manuel Ascano, Neelanjan Mukherjee, Pradeep Bandaru, Jason B Miller, Jeffrey D Nusbaum, David L Corcoran, Christine Langlois, Mathias Munschauer, Scott Dewell, Markus Hafner,[...]. Nature 2012
436
15

GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
Marjelo A Mines, Christopher J Yuskaitis, Margaret K King, Eleonore Beurel, Richard S Jope. PLoS One 2010
156
14


Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh, Alcino J Silva. Nat Med 2008
585
14

Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
Zhong-Hua Liu, Tianjian Huang, Carolyn Beebe Smith. Neurobiol Dis 2012
48
29

The pathophysiology of fragile X (and what it teaches us about synapses).
Asha L Bhakar, Gül Dölen, Mark F Bear. Annu Rev Neurosci 2012
259
14

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.
I J Weiler, S A Irwin, A Y Klintsova, C M Spencer, A D Brazelton, K Miyashiro, T A Comery, B Patel, J Eberwine, W T Greenough. Proc Natl Acad Sci U S A 1997
495
13

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Q J Yan, M Rammal, M Tranfaglia, R P Bauchwitz. Neuropharmacology 2005
392
13

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
226
13

Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology.
Tsuyoshi Udagawa, Natalie G Farny, Mira Jakovcevski, Hanoch Kaphzan, Juan Marcos Alarcon, Shobha Anilkumar, Maria Ivshina, Jessica A Hurt, Kentaro Nagaoka, Vijayalaxmi C Nalavadi,[...]. Nat Med 2013
83
15

Absence of expression of the FMR-1 gene in fragile X syndrome.
M Pieretti, F P Zhang, Y H Fu, S T Warren, B A Oostra, C T Caskey, D L Nelson. Cell 1991
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.